Galderma Group AG (XSWX:GALD) Buyback Yield %: 0.69 (As of Jul. 02, 2026)


XSWX:GALD Galderma Group AG XSWX:GALD
15 GF Score
Price CHF178.85
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG Buyback Yield %?

Galderma Group AG XSWX:GALD -2.75% 15 Buyback Yield % is 0.69 as of Jul. 02, 2026. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 293 Drug Manufacturers companies, Galderma Group AG ranks better than 80.55% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Galderma Group AG's current buyback yield was 0.69%.

Galderma Group AG Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Buyback Yield % Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 -8.03 0.76

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial 0.00 -12.36 -8.03 0.97 0.76

XSWX:GALD vs ZTS, UTHR, VTRS: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's Buyback Yield % falls into.


XSWX:GALD
15GF Score
Galderma Group AG XSWX:GALD
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Galderma Group AG's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-289.275 + 0) / 38023.6349
=0.76%

Galderma Group AG's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-289.275 + 0) / 38023.6349
=0.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.69 mean?
Galderma Group AG (XSWX:GALD) has a Buyback Yield % of 0.69 as of Jul. 02, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Galderma Group AG and its competitors. According to the industry distribution chart, Galderma Group AG ranks #57 out of 293 companies in the Drug Manufacturers industry, placing it in the top 19.5%.
Is Galderma Group AG's Buyback Yield % too high?
Galderma Group AG's current Buyback Yield % is 0.69. Based on the distribution chart, Galderma Group AG ranks #57 out of 293 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Galderma Group AG ranks #57 out of 293 companies for Buyback Yield %. This places Galderma Group AG in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Buyback Yield % is 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Buyback Yield % of 0.69. The current Buyback Yield % is 0.69. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Buyback Yield % is 0.69 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score

Get the complete analysis for XSWX:GALD

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF178.85
Price